LeonaBio (LONA) Receivables - Other (2019 - 2024)
LeonaBio (LONA) posted quarterly Receivables - Other of $4.1 million for Q4 2024, up 157.94% year-over-year from $1.6 million in Q1 2024, and little changed quarter-over-quarter from $4.1 million in Q3 2024.
LeonaBio (LONA) Receivables - Other (2019 - 2024) Analysis & Trends
LeonaBio (LONA) has reported Receivables - Other for 6 consecutive years, with $4.1 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Receivables - Other rose 157.94% year-over-year to $4.1 million; the TTM figure through Dec 2024 stood at $4.1 million (up 157.94% YoY), while the FY2024 annual figure was $4.1 million, up 157.94% from the prior year.
- Receivables - Other was little changed at $4.1 million in Q4 2024 per LONA's latest filing, from $4.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $4.1 million in Q3 2024 and bottomed at $1.2 million in Q4 2022.
- Historically, Receivables - Other has averaged $2.3 million across 5 years, with a median of $2.1 million in 2021.
- Annual changes were most pronounced in 2020 — Receivables - Other surged 18471.43% — and 2022, when it slumped 47.47%.
- LeonaBio's Receivables - Other stood at $1.3 million in 2020, then jumped by 79.69% to $2.3 million in 2021, then tumbled by 47.47% to $1.2 million in 2022, then surged by 30.4% to $1.6 million in 2023, then jumped by 157.94% to $4.1 million in 2024.
- Business Quant data shows LONA's Receivables - Other at $4.1 million in Q4 2024, $4.1 million in Q3 2024, and $1.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.13 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.23 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 2.08 Mn |
| Sep 30, 2021 | 2.08 Mn |